JESSICA MORENO: Open Payments
NPI 1558146837 · HEATH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,960 in 75 payments from 13 companies in 2025. Trend: 2023 $123 · 2024 $1,671 · 2025 $1,960
Food & beverage: $1,960
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $388 |
| Vanda Pharmaceuticals Inc. | 12 | $349 |
| Alkermes, Inc. | 9 | $244 |
| Janssen Pharmaceuticals, Inc | 8 | $184 |
| E.R. Squibb & Sons, L.L.C. | 11 | $171 |
| Neurocrine BioSciences, Inc. | 4 | $134 |
| Otsuka America Pharmaceutical, Inc. | 6 | $124 |
| Lundbeck LLC | 5 | $115 |
| ABBVIE INC. | 4 | $74 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
Products named: Auvelity, FANAPT, REXULTI, COBENFY, INVEGA SUSTENNA, LYBALVI, INGREZZA, ARISTADA.
Industry payments across TX — which companies pay providers there.
